Lifecore Biomedical Inc
NASDAQ:LFCR
Lifecore Biomedical Inc
Tax Provision
Lifecore Biomedical Inc
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
Tax Provision
-$178k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
33%
|
|
|
Hershey Co
NYSE:HSY
|
Tax Provision
-$252.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
|
General Mills Inc
NYSE:GIS
|
Tax Provision
-$637.5m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
1%
|
|
|
Kellogg Co
NYSE:K
|
Tax Provision
-$304m
|
CAGR 3-Years
14%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-5%
|
|
|
Kraft Heinz Co
NASDAQ:KHC
|
Tax Provision
$1.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mondelez International Inc
NASDAQ:MDLZ
|
Tax Provision
-$1.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-15%
|
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
What is Lifecore Biomedical Inc's Tax Provision?
Tax Provision
-178k
USD
Based on the financial report for Nov 24, 2024, Lifecore Biomedical Inc's Tax Provision amounts to -178k USD.
What is Lifecore Biomedical Inc's Tax Provision growth rate?
Tax Provision CAGR 10Y
33%
Over the last year, the Tax Provision growth was 50%.
You don't have any saved screeners yet